Adbry (tralokinumab-ldrm)

**Product type:** Human Prescription Drug

**Active ingredient:** TRALOKINUMAB

**Strength:** 300 mg/2mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** LEO Pharma Inc.

**Marketing category:** BLA (BLA761180)

**Pharmacologic class:** Interleukin-13 Antagonist [EPC], Interleukin-13 Antagonists [MoA]